The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.
- Past awards
- 12
- 12 new
- Median first-year cost
- $633,593
- $7,788,166 in all
- Institutions
- 10
- 12 contact PIs
Awards by fiscal year
0
0
0
0
0
0
12
0
0
0
0
0
0
14151617181920212223242526
Fiscal years 2014 to 2026.
Most frequent institutions
- BUCK INSTITUTE FOR RESEARCH ON AGING3
- ALBERT EINSTEIN COLLEGE OF MEDICINE1
- BROWN UNIVERSITY1
- CLEVELAND CLINIC LERNER COM-CWRU1
- HARVARD SCHOOL OF PUBLIC HEALTH1
and 5 other institutions
Most frequent study sections
- Special Emphasis Panel (ZAG1 ZIJ-P (J4))12
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| FY2020 | Lowering Mitochondrial ATP Synthase Activity Slows Aging and Alzheimer's Disease1R01AG067331-01 | Petrascheck, Michael | SCRIPPS RESEARCH INSTITUTE, THE, CA | First-year cost $917,648 | Study section ZAG1 |
| FY2020 | Mechanisms of the signaling metabolite β-hydroxybutyrate in Alzheimer's disease and the aging brain1R01AG067333-01 | Newman, John C | BUCK INSTITUTE FOR RESEARCH ON AGING, CA | First-year cost $781,500 | Study section ZAG1 |
| FY2020 | A geroscience approach for treating Alzheimer's disease1R01AG067193-01 | Darvas, Martin CLadiges, Warren C | UNIVERSITY OF WASHINGTON, WA | First-year cost $777,433 | Study section ZAG1 |
| FY2020 | Role of Lifespan Intervention on the Regulation and Progression of Alzheimer's Disease1R01AG067289-01 | Rizzo, Stacey J | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | First-year cost $773,850 | Study section ZAG1 |
| FY2020 | Metabolism of Alzheimer’s Disease: systems and cellular networks1R01AG067330-01 | Anderson, Rozalyn M. | UNIVERSITY OF WISCONSIN-MADISON, WI | First-year cost $703,396 | Study section ZAG1 |
| FY2020 | Hypothalamus-driven anti-aging processes impact murine models of Alzheimer's Disease1R01AG067329-01 | Horvath, Tamas L | YALE UNIVERSITY, CT | First-year cost $646,113 | Study section ZAG1 |
| FY2020 | Neuronal FXR as a potential therapeutic target for Alzheimer's disease1R01AG067325-01 | Andersen, Julie KayLithgow, Gordon J | BUCK INSTITUTE FOR RESEARCH ON AGING, CA | First-year cost $621,072 | Study section ZAG1 |
| FY2020 | The effect of life span modifying interventions on Alzheimer's Disease in Drosophila and Mice.1R01AG067306-01 | Helfand, Stephen L | BROWN UNIVERSITY, RI | First-year cost $589,643 | Study section ZAG1 |
| FY2020 | Targeting Aging to prevent Alzheimer's Disease: the Geroscience Approach1R01AG067326-01 | Lithgow, Gordon J | BUCK INSTITUTE FOR RESEARCH ON AGING, CA | First-year cost $581,874 | Study section ZAG1 |
| FY2020 | A systems approach for identifying geroprotector synergy in Alzheimer's disease1R01AG067312-01 | Huffman, Derek MajorTu, Zhidong | ALBERT EINSTEIN COLLEGE OF MEDICINE, NY | First-year cost $522,660 | Study section ZAG1 |
| FY2020 | Adipokines, Aging, and Alzheimers Disease1R01AG067146-01 | Fox, Paul L | CLEVELAND CLINIC LERNER COM-CWRU, OH | First-year cost $474,227 | Study section ZAG1 |
| FY2020 | Reversing Loss of Metabolic Homeostasis to Ameliorate Alzheimer's Disease Pathogenicity1R01AG067106-01 | Mair, William B | HARVARD SCHOOL OF PUBLIC HEALTH, MA | First-year cost $398,750 | Study section ZAG1 |
Newest fiscal year first, then first-year cost.
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-13-0.3.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.